Abstract:Insulin resistance (IR) is a major pathophysiologic defect in type 2 diabetes and obesity, caused by generation of mtROS led to NLRP3 inflammasome activation. M1-like macrophages has been found to sense this blowing out mtROS and mediate downstream inflammatory under “lipotoxicity” in causing abnormal metabolic homeostasis. This paper aims to explore the role of exosomal miRNAs derived from bone marrow-derived macrophages (BMDMs) under LPS+paltimate stress in the development of NLRP3 dependent inflammatory responses and IR. Here, we show that lipotoxicity-polarized BMDMs-derived secrete miRNA-containing exosomes (Exos) leading to the accumulation of fragmented dysfunctional mitochondria, which impairs glucose tolerance and insulin sensitivity when given to WT mice and triggers significant increased pro-inflammatory chemokine and cytokine production level of IL-1β, MCP-1, IL-6, and TNF-α result from mitophagy inhibition. We found that miR-27-3p is highly expressed in M1 Exos and functions as an insulin inhibiter by leading mitochondria fission rather than fusion, as well as mitophagy impairment resulted in NLRP3 inflammatory activation and the development of IR both in vivo and in vitro. Expressing miR-27-3p mimic Exos recapitulate the effects of lipotoxicity-polarized macrophages-derived M1 Exos on metabolic phenotypes. A dual-luciferase reporter assay confirmed that Miro1 is a bona fide target mRNA of miR-27-3p, which couples to the mitochondrial transport and fusion machinery leads to abnormal mitophagy through Miro1/Mfn pathway in modulating mitophagy deficient-mediated inflammation and insulin sensitivity. Taken together, these data suggest miR-27-3p/Miro1/Mfn could be a new therapeutic target for metabolic disease.Funding Information: This study is supported by grants from the National Natural Scientific Foundation of China (grant number 81873780) , Education Department of Hunan Province (19A058), Project of Changsha Science and Technology (kq2004077), the Application Characteristic Discipline of Hunan Province to Jianming Li; by grants from the National Natural Science Foundation of China (No. 81670747), Wuhan University Top-Notch Talent Fund (2042016kf0149), Hubei Provincial Natural Fund Key Projects (2015CFA075), and Wuhan University Outstanding Talent Startup Fund (907/410100006) to Sijun Yang.Declaration of Interests: The authors declare no competing financial interests.Ethics Approval Statement: All experimental procedures were approved by Changsha Medical University Animal Care and Use Committee and were conducted in full accordance with the Guide for the Care and Use of Laboratory Animals.

Bone marrow macrophage‐derived exosomal miR‐143‐5p contributes to insulin resistance in hepatocytes by repressing MKP5

Exosomal transfer of obesity adipose tissue for decreased miR-141-3p mediate insulin resistance of hepatocytes

Islet‐derived exosomal miR‐204 accelerates insulin resistance in skeletal muscle by suppressing sirtuin 1: An in vivo study in a mouse model of high‐fat diet–induced obesity

Bone marrow mesenchymal stem cell-derived exosomes reduce insulin resistance and obesity in mice via the PI3K/AKT signaling pathway

Hepatocyte-derived exosomes from early onset obese mice promote insulin sensitivity through miR-3075

Lipotoxicity-polarised macrophage-derived exosomes regulate mitochondrial fitness through Miro1-mediated mitophagy inhibition and contribute to type 2 diabetes development in mice

Lipotoxicity-Polarized Macrophages – Derived Mir-27-3p Contributes to Mitochondrial Fitness Dependent Pro-Inflammatory Response and Aggravates Insulin Resistance Through Miro1 /mfn Pathway

MiR-690, an exosomal-derived miRNA from M2-polarized macrophages, improves insulin sensitivity in obese mice

Hepatic miR‐125b inhibits insulin signaling pathway by targeting PIK3CD

291-LB: Long Noncoding RNA H19 Improves Insulin Resistance in Skeletal Muscle by Regulating Heterogeneous Nuclear Ribonucleoprotein A1

Long non-coding RNA H19 improves insulin resistance in skeletal muscle by regulating heterogeneous nuclear ribonucleoprotein A1

Circulating Mir-143-3p Inhibition Protects Against Insulin Resistance in Metabolic Syndrome Via Targeting of the Insulin-Like Growth Factor 2 Receptor.

Bone marrow mesenchymal stem cells derived exosomal miRNAs can modulate diabetic bone-fat imbalance

Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes

Bone Marrow Mesenchymal Stem Cells-Derived Exosomal MiR-29b-3p Regulates Aging-Associated Insulin Resistance.

Hypertrophic Adipocyte-Derived Exosomal miR-802-5p Contributes to Insulin Resistance in Cardiac Myocytes Through Targeting HSP60

Adipocyte-Derived Exosomal MiR-27a Induces Insulin Resistance in Skeletal Muscle Through Repression of PPARγ.

Skeletal muscle-derived exosomal miR-146a-5p inhibits lipogenesis by mediating muscle-fat axis and targeting GDF5-PPARγsignaling

MicroRNA 152 Regulates Hepatic Glycogenesis by Targeting PTEN.

Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling

Pancreatic Β Cell Microrna-26A Alleviates Type 2 Diabetes by Improving Peripheral Insulin Sensitivity and Preserving Β Cell Function